Angel F. López

18.1k total citations · 2 hit papers
275 papers, 13.7k citations indexed

About

Angel F. López is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Angel F. López has authored 275 papers receiving a total of 13.7k indexed citations (citations by other indexed papers that have themselves been cited), including 165 papers in Immunology, 75 papers in Molecular Biology and 58 papers in Oncology. Recurrent topics in Angel F. López's work include Immune Cell Function and Interaction (76 papers), Immune Response and Inflammation (76 papers) and Monoclonal and Polyclonal Antibodies Research (36 papers). Angel F. López is often cited by papers focused on Immune Cell Function and Interaction (76 papers), Immune Response and Inflammation (76 papers) and Monoclonal and Polyclonal Antibodies Research (36 papers). Angel F. López collaborates with scholars based in Australia, United States and United Kingdom. Angel F. López's co-authors include M A Vadas, Joanna M. Woodcock, Jennifer R. Gamble, C. Glenn Begley, Mathew A. Vadas, Colin J. Sanderson, Frank C. Stomski, Timothy R. Hercus, Nicos A. Nicola and Hayley S. Ramshaw and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Angel F. López

269 papers receiving 13.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recombinant human interleukin 5 is a selective activator of human eosinophil function.

1988 809 citations Angel F. López et al. The Journal of Experimental Medicine profile →
Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival.

1986 623 citations Angel F. López et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Angel F. López Australia	63	6.9k	3.6k	2.9k	2.3k	2.3k	275	13.7k
Kazuo Sugamura Japan	78	12.2k 1.8×	4.9k 1.3×	4.0k 1.4×	1.1k 0.5×	1.8k 0.8×	304	20.8k
Clifford A. Lowell United States	85	11.8k 1.7×	6.5k 1.8×	2.7k 0.9×	2.0k 0.9×	1.9k 0.8×	227	20.7k
Walter Newman United States	51	9.0k 1.3×	3.1k 0.8×	2.6k 0.9×	1.1k 0.5×	2.0k 0.9×	108	16.3k
Cees van Kooten Netherlands	69	12.3k 1.8×	3.5k 1.0×	2.1k 0.7×	1.5k 0.7×	933 0.4×	365	19.6k
Chikao Morimoto United States	74	8.4k 1.2×	5.1k 1.4×	5.6k 1.9×	1.1k 0.5×	914 0.4×	339	18.5k
Martin Turner United Kingdom	67	8.6k 1.3×	7.8k 2.1×	2.7k 1.0×	1.5k 0.7×	763 0.3×	208	17.6k
Brian J. Nickoloff United States	76	9.1k 1.3×	5.3k 1.5×	4.4k 1.5×	691 0.3×	1.8k 0.8×	239	19.0k
Hajime Karasuyama Japan	64	10.4k 1.5×	5.4k 1.5×	2.4k 0.8×	727 0.3×	2.2k 1.0×	214	17.3k
Giovanna Tosato United States	74	5.9k 0.9×	4.1k 1.1×	8.0k 2.8×	1.0k 0.4×	1.4k 0.6×	242	15.8k
Fabienne Mackay Australia	69	13.6k 2.0×	5.1k 1.4×	2.6k 0.9×	1.3k 0.6×	2.4k 1.1×	146	22.2k

Countries citing papers authored by Angel F. López

Since Specialization

Citations

This map shows the geographic impact of Angel F. López's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angel F. López with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angel F. López more than expected).

Fields of papers citing papers by Angel F. López

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angel F. López. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angel F. López. The network helps show where Angel F. López may publish in the future.

Co-authorship network of co-authors of Angel F. López

This figure shows the co-authorship network connecting the top 25 collaborators of Angel F. López. A scholar is included among the top collaborators of Angel F. López based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angel F. López. Angel F. López is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thompson, Emma J., Denis Tvorogov, Gelareh Farshid, et al.. (2024). Interleukin-3 production by basal-like breast cancer cells is associated with poor prognosis. Growth Factors. 42(2). 49–61. 2 indexed citations

Lim, Kelly, Winnie L. Kan, Pramod C. Nair, et al.. (2024). CBL mutations in chronic myelomonocytic leukemia often occur in the RING domain with multiple subclones per patient: Implications for targeting. PLoS ONE. 19(9). e0310641–e0310641.

Nair, Pramod C., Jacob Piehler, Denis Tvorogov, et al.. (2023). Next-Generation JAK2 Inhibitors for the Treatment of Myeloproliferative Neoplasms: Lessons from Structure-Based Drug Discovery Approaches. Blood Cancer Discovery. 4(5). 352–364. 12 indexed citations

Wang, Hao, Kwok Ho Yip, Simon P. Keam, et al.. (2023). Dual inhibition of airway inflammation and fibrosis by common β cytokine receptor blockade. Journal of Allergy and Clinical Immunology. 153(3). 672–683.e6. 7 indexed citations

Schembri, Mark A., et al.. (2021). Short‐term Oral Steroids Significantly Improves Chronic Rhinosinusitis Without Nasal Polyps. The Laryngoscope. 131(10). E2618–E2626. 5 indexed citations

Cañete, Pablo F., Rebecca A. Sweet, Paula González-Figueroa, et al.. (2019). Regulatory roles of IL-10–producing human follicular T cells. The Journal of Experimental Medicine. 216(8). 1843–1856. 64 indexed citations

Gartlan, Kate H., Motoko Koyama, Katie E. Lineburg, et al.. (2019). Donor T-cell–derived GM-CSF drives alloantigen presentation by dendritic cells in the gastrointestinal tract. Blood Advances. 3(19). 2859–2865. 19 indexed citations

Tvorogov, Denis, Danièl Thomas, Nicholas P. D. Liau, et al.. (2018). Accumulation of JAK activation loop phosphorylation is linked to type I JAK inhibitor withdrawal syndrome in myelofibrosis. Science Advances. 4(11). eaat3834–eaat3834. 41 indexed citations

Broughton, Sophie E., Timothy R. Hercus, Tracy L. Nero, et al.. (2016). Conformational Changes in the GM-CSF Receptor Suggest a Molecular Mechanism for Affinity Conversion and Receptor Signaling. Structure. 24(8). 1271–1281. 40 indexed citations

10.

Ramshaw, Hayley S., Emily J. Jaehne, Peter McCarthy, et al.. (2013). Locomotor hyperactivity in 14-3-3ζ KO mice is associated with dopamine transporter dysfunction. Translational Psychiatry. 3(12). e327–e327. 25 indexed citations

11.

Hercus, Timothy R., Urmi Dhagat, Winnie L. Kan, et al.. (2013). Signalling by the beta c family of cytokines. Cytokine & Growth Factor Reviews. 24(3). 2 indexed citations

12.

Tettamanti, Sarah, Virna Marin, Irene Pizzitola, et al.. (2013). Targeting of acute myeloid leukaemia by cytokine‐induced killer cells redirected with a novel CD123‐specific chimeric antigen receptor. British Journal of Haematology. 161(3). 389–401. 175 indexed citations

13.

Yu, Chunping, et al.. (2010). Evidence that vitamin D3 promotes mast cell–dependent reduction of chronic UVB-induced skin pathology in mice. The Journal of Experimental Medicine. 207(3). 455–463. 90 indexed citations

14.

Kim, Sohee, Melanie Prout, Hayley S. Ramshaw, et al.. (2009). Cutting Edge: Basophils Are Transiently Recruited into the Draining Lymph Nodes during Helminth Infection via IL-3, but Infection-Induced Th2 Immunity Can Develop without Basophil Lymph Node Recruitment or IL-3. The Journal of Immunology. 184(3). 1143–1147. 120 indexed citations

15.

Mu, Fi‐Tjen, Robert K. Andrews, Jane F. Arthur, et al.. (2008). A functional 14-3-3ζ–independent association of PI3-kinase with glycoprotein Ibα, the major ligand-binding subunit of the platelet glycoprotein Ib-IX-V complex. Blood. 111(9). 4580–4587. 35 indexed citations

16.

Asquith, Kelly L., Hayley S. Ramshaw, Philip M. Hansbro, Kenneth W. Beagley, & Angel F. López. (2008). The IL-3/IL-/GM-CSF Common B Receptor Plays a Pivotal Role in the Regulation of Th2 Immunity and Allergic Airway Inflammation. QUT ePrints (Queensland University of Technology). 95 indexed citations

17.

Thomas, Danièl, Mathew A. Vadas, & Angel F. López. (2004). Regulation of haematopoiesis by growth factors – emerging insights and therapies. Expert Opinion on Biological Therapy. 4(6). 869–879. 17 indexed citations

18.

Iversen, Per Ole, Douglas S. Robinson, Ying Sun, et al.. (1997). The GM-CSF Analogue E21R Induces Apoptosis of Normal and Activated Eosinophils. American Journal of Respiratory and Critical Care Medicine. 156(5). 1628–1632. 17 indexed citations

19.

Iversen, Per Ole, Timothy R. Hercus, Joanna M. Woodcock, et al.. (1997). The Apoptosis-inducing Granulocyte-Macrophage Colony-stimulating Factor (GM-CSF) Analog E21R Functions through Specific Regions of the Heterodimeric GM-CSF Receptor and Requires Interleukin-1β-converting Enzyme-like Proteases. Journal of Biological Chemistry. 272(15). 9877–9883. 12 indexed citations

20.

Macpherson, Janet L., Angel F. López, & Steven A. Krilis. (1992). Co-Culture of Human Bone Marrow Cells with a Mastocytosis Cell Strain Induces Mast Cell/Basophil Differentiation. International Archives of Allergy and Immunology. 99(2-4). 346–349. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact